Cubicle to CEO 296. From Launch to 20K Users In Under 6 Months: How SheMed Turned Regulation Into Rapid Growth
Apr 28, 2025
Olivia Ferro and Chloe Ferro, co-founders of SheMed, a pioneering women's healthcare startup in the UK, share insights on their rapid growth to over 20,000 users. They reveal the powerful strategy of requiring blood tests to build trust, leading to a remarkable increase in sign-ups. The sisters discuss tackling the complexities of the GLP-1 market and empowering women through transparent healthcare solutions. Their innovative marketing and commitment to safety have set them apart in the crowded wellness industry, illustrating that sometimes, making access harder can spike demand.
AI Snips
Chapters
Transcript
Episode notes
UK Market Gap for Women
- SheMed chose the UK due to a market gap: no female-focused GLP-1 programs despite 80% of users being women.
- They aimed to fill this unmet need with a clinically rigorous, women-centric health program.
Leveraging Partnerships for Growth
- SheMed leveraged a sister brand's clinical and tech teams to launch quickly and scale fast.
- External investors complemented existing partnerships, speeding growth beyond what was possible alone.
Use Friction to Build Trust
- Adding friction like mandatory blood tests and verifications can actually increase customer trust.
- Prioritize safety and credibility over convenience to stand out in crowded markets.